CVS HEALTH Corp
CVSAPI behind this page
CVS Q1 2026 request
Playground key active
/api/financials?ticker=CVS&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 62,226 | 57,669 | +7.9% |
| Service | 3,835 | 3,579 | +7.2% |
| Premiums Earned Net | 33,791 | 32,820 | +3.0% |
| Net Investment Income | 574 | 520 | +10.4% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 112 | 119 | -5.9% |
| Corporate/ Other · Corporate/ Other | 112 | 119 | -5.9% |
| Health Care Benefits | 462 | 387 | +19.4% |
| Health Care Benefits · Operating Segments | 462 | 387 | +19.4% |
| Revenue | 100,426 | 94,588 | +6.2% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 126 | 133 | -5.3% |
| Health Care Benefits · Intersegment Elimination | -32 | -18 | -77.8% |
| Health Care Benefits · Operating Segments | 35,971 | 34,810 | +3.3% |
| Health Services · Intersegment Elimination | -5,628 | -5,352 | -5.2% |
| Health Services · Operating Segments | 2,582 | 2,266 | +13.9% |
| Health Services · Operating Segments | 20,506 | 18,068 | +13.5% |
| Health Services · Operating Segments | 25,149 | 23,114 | +8.8% |
| Health Services · Operating Segments | 48,237 | 43,462 | +11.0% |
| Pharmacy & Consumer Wellness · Intersegment Elimination | -10,237 | -10,359 | +1.2% |
| Pharmacy & Consumer Wellness · Operating Segments | 31,989 | 31,912 | +0.2% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -15,897 | -15,729 | -1.1% |
| Operating Segments and Corporate/ Other | 116,323 | 110,317 | +5.4% |
| Cost of Revenue | 55,444 | 51,057 | +8.6% |
Show Business Segments breakouts |
|||
| Health Services · Operating Segments | 44,719 | 40,115 | +11.5% |
| Pharmacy & Consumer Wellness · Operating Segments | 25,790 | 25,804 | -0.1% |
| Policyholder Benefits And Claims Incurred Net | 29,358 | 29,135 | +0.8% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 46 | 46 | 0.0% |
| Health Care Benefits · Operating Segments | 28,579 | 28,637 | -0.2% |
| Health Services · Operating Segments | 1,302 | 1,047 | +24.4% |
| Other Cost And Expense Operating | 10,944 | 11,022 | -0.7% |
| Total Costs & Expenses | 95,746 | 91,214 | +5.0% |
| Operating Income | 4,680 | 3,374 | +38.7% |
| Interest Expense | -774 | -785 | +1.4% |
| Other Non-Operating Income (Expense) | 32 | 28 | +14.3% |
| Income Before Taxes | 3,938 | 2,617 | +50.5% |
| Income Tax Expense (Benefit) | 981 | 835 | +17.5% |
| Net Income | 2,957 | 1,782 | +65.9% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 14 | 3 | +366.7% |
| Parent | 2,943 | 1,779 | +65.4% |
| Retained Earnings | 2,943 | 1,779 | +65.4% |
| Net Income Loss Attributable To Noncontrolling Interest | -14 | -3 | -366.7% |
| Net Income | 2,943 | 1,779 | +65.4% |
| EPS (Basic) | 2.31 | 1.41 | +63.8% |
| EPS (Diluted) | 2.3 | 1.41 | +63.1% |
| Wtd Avg Shares (Basic) | 1,273 | 1,261 | +1.0% |
| Wtd Avg Shares (Diluted) | 1,279 | 1,264 | +1.2% |
| Comprehensive Income | 2,738 | 1,958 | +39.8% |
| Net Income Loss Available To Common Stockholders Basic | 2,943 | 1,779 | +65.4% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 29,281 | 28,642 | +2.2% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 9,542 | 10,076 | -5.3% |
| Short-Term Investments | 2,260 | 2,578 | -12.3% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 2,104 | 2,426 | -13.3% |
| Mortgage loans | 156 | 152 | +2.6% |
| Accounts Receivable | 40,992 | — | — |
| Inventory | 17,770 | 17,385 | +2.2% |
| Other Assets Current | 4,253 | 3,527 | +20.6% |
| Total Current Assets | 74,817 | 73,191 | +2.2% |
| Non-Current Assets | |||
| Long Term Investments | 32,407 | 28,906 | +12.1% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 26,287 | 23,618 | +11.3% |
| Mortgage loans | 1,339 | 1,346 | -0.5% |
| Other Investments | 4,781 | 3,942 | +21.3% |
| Operating Lease Right-of-Use Assets | 14,741 | 15,704 | -6.1% |
| Goodwill | 85,478 | 91,203 | -6.3% |
| Other Non-Current Assets | 7,424 | 5,231 | +41.9% |
| Total Assets | 252,974 | 255,585 | -1.0% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 13,037 | 12,856 | +1.4% |
| Intangible Assets Net Excluding Goodwill | 25,070 | 26,570 | -5.6% |
| Current Liabilities | |||
| Accounts Payable Trade Current | 16,922 | 16,534 | +2.3% |
| Pharmacy Claims And Discounts Payable Current | 26,149 | 25,797 | +1.4% |
| Accrued Liabilities | 22,258 | 22,369 | -0.5% |
| Other Insurance Liabilities Current | 1,075 | 1,570 | -31.5% |
| Operating Lease Liability Current | 1,904 | 1,909 | -0.3% |
| Long Term Debt And Capital Lease Obligations Current | 2,580 | 4,411 | -41.5% |
| Total Current Liabilities | 86,406 | 88,961 | -2.9% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 13,330 | 14,594 | -8.7% |
| Deferred Tax Liabilities | 3,771 | 3,664 | +2.9% |
| Other Insurance Liabilities Noncurrent | 4,592 | 4,873 | -5.8% |
| Other Non-Current Liabilities | 6,707 | 5,419 | +23.8% |
| Total Liabilities | 175,337 | 178,475 | -1.8% |
| Other Liabilities | |||
| Liability For Claims And Claims Adjustment Expense And Health Care Organization Accounts Payable To Third Party Payor | 15,518 | 15,112 | +2.7% |
| Long Term Debt And Capital Lease Obligations | 60,531 | 59,040 | +2.5% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 50,679 | 49,837 | +1.7% |
| Treasury Stock Common Value | -36,706 | -36,735 | +0.1% |
| Retained Earnings | 63,282 | 63,768 | -0.8% |
| Accumulated Other Comprehensive Income | 201 | 59 | +240.7% |
| Total Stockholders' Equity | 77,456 | 76,929 | +0.7% |
| Minority Interest | 181 | 181 | 0.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 77,637 | 77,110 | +0.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Gain Loss Including Portion Attributable To Noncontrolling Interest | -238 | -211 | -12.8% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | 7 | -4 | +275.0% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | 212 | 225 | -5.8% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | -38 | -183 | +79.2% |
| Accumulated Other Comprehensive Income | 201 | 59 | +240.7% |
| Aoci Including Portion Attributable To Noncontrolling Interest | 201 | 59 | +240.7% |
| Change in discount rate on long-duration insurance reserves: | 258 | 232 | +11.2% |
| Common Stock | 18 | 18 | 0.0% |
| Common Stock Including Additional Paid In Capital | 50,679 | 49,837 | +1.7% |
| Noncontrolling Interest | 181 | 181 | 0.0% |
| Parent | 77,456 | 76,929 | +0.7% |
| Retained Earnings | 63,282 | 63,768 | -0.8% |
| Treasury Stock Common | -36,706 | -36,735 | +0.1% |
| Total Liabilities & Equity | 252,974 | 255,585 | -1.0% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Proceeds From Customers | 94,201 | 90,809 | +3.7% |
| Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies | -50,551 | -48,433 | -4.4% |
| Payments For Insurance Benefits | -28,398 | -28,477 | +0.3% |
| Payments To Suppliers And Employees | -10,775 | -8,690 | -24.0% |
| Proceeds From Interest And Dividends Received | 526 | 497 | +5.8% |
| Interest Paid | -1,091 | -1,012 | -7.8% |
| Income Taxes Paid | 337 | -138 | +344.2% |
| Net Cash from Operations | 4,249 | 4,556 | -6.7% |
| Depreciation & Amortization | 1,115 | 1,154 | -3.4% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 111 | 104 | +6.7% |
| Health Care Benefits | 340 | 405 | -16.0% |
| Health Services | 258 | 261 | -1.1% |
| Pharmacy & Consumer Wellness | 406 | 384 | +5.7% |
| Stock-Based Compensation | 266 | 126 | +111.1% |
| Deferred Income Taxes And Other Items | -91 | -169 | +46.2% |
| Change in Accounts Receivable | -1,205 | -3,053 | +60.5% |
| Change in Inventory | 1,476 | 722 | +104.4% |
| Increase Decrease In Other Operating Assets | 479 | -1,101 | +143.5% |
| Change in Accounts Payable | -562 | 2,619 | -121.5% |
| Increase Decrease In Insurance Liabilities | 10 | 364 | -97.3% |
| Increase Decrease In Other Operating Liabilities | -196 | 1,876 | -110.4% |
| Investing Activities | |||
| Proceeds From Sale And Maturity Of Marketable Securities | 4,159 | 3,534 | +17.7% |
| Payments To Acquire Investments | -4,186 | -3,552 | -17.8% |
| Capital Expenditures | -849 | -743 | -14.3% |
| Payments To Acquire Businesses Net Of Cash Acquired | -5 | -20 | +75.0% |
| Other Investing Activities | 7 | 19 | -63.2% |
| Net Cash from Investing | -874 | -762 | -14.7% |
| Financing Activities | |||
| Repayments Of Long Term Debt | -1,518 | -743 | -104.3% |
| Payments Of Dividends | -847 | -840 | -0.8% |
| Proceeds From Stock Options Exercised | 103 | 144 | -28.5% |
| Tax Withholding for Share Compensation | -9 | -11 | +18.2% |
| Proceeds From Payments For Other Financing Activities | -47 | -23 | -104.3% |
| Net Cash from Financing | -2,318 | -2,332 | +0.6% |
| Other Cash Flow | |||
| Net Change in Cash | 1,057 | 1,462 | -27.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,769 | 10,346 | -5.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.